A Study to Evaluate ASP0367 in Participants With Primary Mitochondrial Myopathy

NCT04641962 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

34

Enrollment

INDUSTRY

Sponsor class

Stopped Due to failure to meet the pre-specified criteria for efficacy

Conditions

Primary Mitochondrial Myopathy

Interventions

DRUG: Bocidelpar
DRUG: Placebo

Sponsor

Astellas Pharma Inc